国际医学控股股东股票质押延期购回公告深度解读
主要内容概览
西安国际医学投资股份有限公司（证券代码：000516，简称“国际医学”）于2026年5月14日发布公告，披露控股股东陕西世纪新元商业管理有限公司（简称“世纪新元”）部分持股股票质押式回购交易已办理延期购回。本次公告对质押延期的情况、控股股东整体质押比例、后续风险及资金安排等方面进行了详细说明，信息高度透明。
公告要点与详细信息
- 1. 质押延期基本情况：
- 世纪新元将其持有的30,900,000股公司股份进行质押延期，约占其持股总数的5.02%，占公司总股本的1.38%。
- 本次质押起始日为2023年11月13日，原到期日为2026年5月12日，现延期至2026年10月27日。
- 质权人为开源证券股份有限公司，质押用途为项目建设资金。
- 本次质押股份均为无限售流通股，且并非补充质押。
- 2. 控股股东及一致行动人累计质押情况：
- 截至公告日，世纪新元持股616,061,198股，占公司总股本27.52%；累计质押489,770,000股，质押比例高达79.50%，占公司总股本的21.88%。
- 一致行动人申华控股集团有限公司持股13,510,083股，几乎全部（99.63%）已质押。
- 另一自然人股东曹鹤玲持股42,097,770股，暂无质押，但其未质押股份中有31,573,327股为限售，占其持股的75%。
- 控股股东及一致行动人合计持股671,669,051股，占公司总股本30%；累计质押503,230,000股，整体质押率为74.92%，占总股本的22.48%。
- 3. 质押到期及潜在风险：
- 未来半年内到期质押股份为104,800,000股，占世纪新元持股的17.01%，对应融资金额2.84亿元。
- 未来一年内到期质押股份为226,730,000股，占世纪新元持股的36.80%，对应融资金额5.33亿元。
- 公司声明目前不存在平仓风险，世纪新元资信状况良好，还款来源包括投资收益、分红、其他收入等，若出现风险将积极应对，如补充质押、部分偿还或提前购回等。
- 4. 其他重要信息：
- 本次质押延期不涉及新增融资安排。
- 控股股东和一致行动人无非经营性资金占用、违规担保等损害上市公司利益的情况。
- 公司将持续关注质押情况，并及时披露相关信息。
对股东和投资者的影响分析
- 高质押率风险： 控股股东及一致行动人整体质押率较高，短期和中期内有较大规模股份到期，若公司股价波动或质权人要求追加保证金，可能对股价产生压力或引发市场关注。
- 公司治理与实际控制权： 公告明确本次质押行为不会导致公司控制权变更，但高质押比例本身为潜在风险点，投资者需密切关注未来质押到期情况和股东还款能力。
- 资金流动性： 世纪新元还款能力较强，目前未见平仓或违约风险，但若后续宏观环境变化或公司经营出现问题，或将引发风险暴露。
- 信息透明度： 公司信息披露及时、详细，有助于投资者理性判断相关风险。
结论
本次公告信息对于投资者极具参考价值。控股股东较高的股份质押比例及较大即将到期规模，是当前投资国际医学股票时不可忽视的重要风险点。建议投资者持续关注公司后续相关公告及市场波动，理性评估投资风险。
免责声明
本文内容基于公司对外公告资料整理，仅供投资者参考，不构成任何投资建议。投资有风险，入市需谨慎。
In-depth Interpretation: Xi’an International Medical’s Controlling Shareholder Stock Pledge Extension
Key Points Overview
Xi’an International Medical Investment Co., Ltd. (Stock Code: 000516, “International Medical”) announced on May 14, 2026, that its controlling shareholder, Shaanxi Shiji Xinyuan Commercial Management Co., Ltd. (“Shiji Xinyuan”), has completed an extension for the repurchase of a portion of its pledged shares. The announcement covers the details of the pledge extension, the overall pledge ratio of controlling shareholders, potential risks, and capital arrangements, ensuring a high level of transparency.
Announcement Highlights and Details
- 1. Pledge Extension Basic Information:
- Shiji Xinyuan extended the pledge of 30,900,000 shares, accounting for 5.02% of its holdings and 1.38% of total company shares.
- The pledge started on November 13, 2023, original maturity date was May 12, 2026, now extended to October 27, 2026.
- Pledgee: Kaiyuan Securities Co., Ltd. The funds are used for project construction.
- All pledged shares are unrestricted and not additional pledges.
- 2. Aggregate Pledge Situation of Controlling Shareholder and Concerted Parties:
- As of the announcement, Shiji Xinyuan holds 616,061,198 shares (27.52% of total shares), with 489,770,000 shares pledged (79.50% of its holdings, 21.88% of total shares).
- Concerted party Shenhua Holdings Group Co., Ltd. holds 13,510,083 shares, with 99.63% pledged.
- Another shareholder, Cao Heling, holds 42,097,770 shares, with no pledges, but 75% of unpledged shares are restricted.
- Total controlling shareholder and concerted parties hold 671,669,051 shares (30% of total shares); pledged 503,230,000 shares (74.92% of their holdings, 22.48% of total shares).
- 3. Pledge Due and Potential Risks:
- In the next six months, 104,800,000 pledged shares will mature, representing 17.01% of Shiji Xinyuan’s holdings and funding 284 million yuan.
- In the next year, 226,730,000 pledged shares will mature, occupying 36.80% of Shiji Xinyuan’s holdings and funding 533 million yuan.
- The company states there is currently no risk of forced liquidation and that Shiji Xinyuan has solid credit and repayment capacity, but if risks arise, supplementary pledges or repayments may be adopted.
- 4. Other Key Information:
- No new financing is involved in this extension.
- No non-operational fund occupation or illegal guarantees by controlling shareholders.
- The company will continue to monitor and disclose new developments.
Potential Impact on Shareholders and Investors
- High Pledge Ratio Risk: The overall pledge rate of controlling shareholders is high, and with a large number of shares due soon, any share price volatility or margin call may pressure the share price or attract market attention.
- Corporate Governance and Control: The company confirms no change in control from this pledge, but the high pledge ratio is a potential risk point, requiring ongoing attention.
- Liquidity: Shiji Xinyuan is currently capable of repayment and no immediate risk is apparent, but any macro or operational issues could expose risks.
- Transparency: The company’s detailed and timely disclosure helps investors make rational judgments.
Conclusion
This announcement is highly relevant for investors. The high proportion of pledged shares and large upcoming maturities are important risk points for International Medical. Investors are advised to keep a close eye on further disclosures and market movements and to assess risk rationally.
Disclaimer
The content is based on public company disclosures and is for information only. It does not constitute investment advice. Investments involve risks, and caution should be exercised.
